Axsome Therapeutics, Inc.
AXSMFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Axsome Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 12 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 11, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Janney Montgomery Scott LLC | 2026-03-31 | 12,030 | Not shown | SEC filing |
| GSA CAPITAL PARTNERS LLP | 2026-03-31 | 2,389 | Not shown | SEC filing |
| HighTower Advisors, LLC | 2026-03-31 | 56,633 | $9.57M | SEC filing |
| Vise Technologies, Inc. | 2026-03-31 | 1,266 | $231K | SEC filing |
| B. Metzler seel. Sohn & Co. AG | 2026-03-31 | 9,241 | $1.56M | SEC filing |
| Legato Capital Management LLC | 2026-03-31 | 15,538 | $2.63M | SEC filing |
| NATIXIS | 2026-03-31 | 301 | $50.9K | SEC filing |
| PRUDENTIAL FINANCIAL INC | 2026-03-31 | 24,573 | $4.15M | SEC filing |
| Thrivent Financial for Lutherans | 2026-03-31 | 1,565 | Not shown | SEC filing |
| Freestone Grove Partners LP | 2026-03-31 | 1,887 | $319K | SEC filing |
| Nicholas Investment Partners, LP | 2026-03-31 | 81,478 | $13.8M | SEC filing |
| MARTINGALE ASSET MANAGEMENT L P | 2026-03-31 | 12,512 | $2.11M | SEC filing |
| E Fund Management (Hong Kong) Co., Ltd. | 2026-03-31 | 89 | $15K | SEC filing |
| Parkside Financial Bank & Trust | 2026-03-31 | 56 | $9.47K | SEC filing |
| Sofinnova Investments, Inc. | 2026-03-31 | 212,747 | $36M | SEC filing |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 2026-03-31 | 16,401 | $2.77M | SEC filing |
| Allianz Asset Management GmbH | 2026-03-31 | 4,000 | $676K | SEC filing |
| US BANCORP \DE\ | 2026-03-31 | 131,414 | $22.2M | SEC filing |
| Knights of Columbus Asset Advisors LLC | 2026-03-31 | 19,677 | $3.33M | SEC filing |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2026-03-31 | 67,491 | $11.4M | SEC filing |
- Each value is checked against Axsome Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 3 rows: the filed value is about 1,000 times too small for the share count at Axsome Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Axsome Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-09 · TABUTEAU HERRIOT: Larger than 65 of the 68 other insider sales of Common Stock on file. SEC filing
- 2026-01-05 · TABUTEAU HERRIOT: Larger than 67 of the 68 other insider sales of Common Stock on file. SEC filing
- 2025-12-02 · TABUTEAU HERRIOT: Larger than 64 of the 68 other insider sales of Common Stock on file. SEC filing
- 2025-11-04 · TABUTEAU HERRIOT: Larger than 66 of the 68 other insider sales of Common Stock on file. SEC filing
- 2025-11-03 · TABUTEAU HERRIOT: Larger than all 68 other insider sales of Common Stock on file. SEC filing
- 2025-09-16 · Jacobson Mark L.: Larger than 62 of the 68 other insider sales of Common Stock on file. SEC filing
- 2024-08-09 · Jacobson Mark L.: Larger than 63 of the 68 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-11 | JEFFS ROGER · Director | Common Stock | S — Open market or private sale | −286 | 249.12 | SEC filing |
| 2026-06-10 | JEFFS ROGER · Director | Common Stock | S — Open market or private sale | −286 | 246.18 | SEC filing |
| 2026-06-10 | Mahony Susan · Director | Common Stock | S — Open market or private sale | −300 | 246.18 | SEC filing |
| 2026-06-10 | Coleman Mark · Director | Common Stock | S — Open market or private sale | −643 | 249.00 | SEC filing |
| 2026-06-09 | TABUTEAU HERRIOT · Chief Executive Officer | Common Stock | S — Open market or private sale | −49,670 | 241.01 | SEC filing |
| 2026-06-09 | Mahony Susan · Director | Common Stock | S — Open market or private sale | −300 | 237.21 | SEC filing |
| 2026-06-09 | Pizzie Nick · Chief Financial Officer | Common Stock | S — Open market or private sale | −33,000 | 240.09 | SEC filing |
| 2026-06-02 | Coleman Mark · Director | Common Stock | S — Open market or private sale | −5,537 | 223.39 | SEC filing |
Showing 8 of 13 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-09 | Pizzie Nick · Chief Financial Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −33,000 | SEC filing |
| 2026-06-09 | TABUTEAU HERRIOT · Chief Executive Officer | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −49,670 | SEC filing |
| 2026-06-09 | Pizzie Nick · Chief Financial Officer | Common Stock | M — Exercise or conversion of derivative security | +33,000 | SEC filing |
| 2026-06-09 | TABUTEAU HERRIOT · Chief Executive Officer | Common Stock | M — Exercise or conversion of derivative security | +49,670 | SEC filing |
| 2026-06-08 | Coleman Mark · Director | Common Stock | M — Exercise or conversion of derivative security | +1,429 | SEC filing |
| 2026-06-08 | Coleman Mark · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −1,429 | SEC filing |
| 2026-06-08 | Mahony Susan · Director | Common Stock | M — Exercise or conversion of derivative security | +1,429 | SEC filing |
| 2026-06-08 | Saad Mark E · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −1,429 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.